Assessment of intravenous immunoglobulin non-responders in Kawasaki disease

Archives of Disease in Childhood

Volumn 96, Issue 11, 2011, Pages 1088-1090

  Hwang, Ja Young ^a   Lee, Kyung Yil ^a   Rhim, Jung Woo ^a   Youn, You Sook ^a   Oh, Jin Hee ^a   Han, Ji Whan ^a   Lee, Joon Sung ^a   Burgner, David ^b,c  

^a The Catholic University of Korea   (South Korea)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

^c UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN;

ARTICLE; CHILD; CHOLESTEROL BLOOD LEVEL; CORONARY ARTERY DISEASE; DISEASE DURATION; DISEASE SEVERITY; FEMALE; FEVER; HUMAN; INCIDENCE; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHIL COUNT; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE;

BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHILD, PRESCHOOL; CHOLESTEROL; CORONARY DISEASE; FEMALE; FEVER; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; LEUKOCYTE COUNT; MALE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NEUTROPHILS; PROSPECTIVE STUDIES; RISK FACTORS; TREATMENT FAILURE;

EID: 80054742591     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.2010.184101     Document Type: Article

References (7)

1. Newburger JW, Takahashi M, Gerber MA, et al. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33. (Pubitemid 41754943)
2. Mori M, Imagawa T, Yasui K, et al. Predictors of coronary artery lesions after intravenous gamma-globulin treatment in Kawasaki disease. J Pediatr 2000;137:177-80. (Pubitemid 30659223)
3. Terai M, Honda T, Yasukawa K, et al. Prognostic impact of vascular leakage in acute Kawasaki disease. Circulation 2003;108:325-30. (Pubitemid 36899024)
4. Yeo JS, Choi JW. Effectiveness of medium-dose intravenous immunoglobulin (1 g/kg) in the treatment of Kawasaki disease. Korean Circ J 2010;40:81-5.
5. Kobayashi T, Inoue Y, Takeuchi K, et al. Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease. Circulation 2006;113:2606-12. (Pubitemid 43948009)
6. Tremoulet AH, Best BM, Song S, et al. Resistance to intravenous immunoglobulin in children with Kawasaki disease. J Pediatr 2008;153:117-21.
7. Marik PE. Dyslipidemia in the critically ill. Crit Care Clin 2006;22:151-9, viii. (Pubitemid 43037115)